glp 1 for heart failure Glucagon-Like Peptide Receptor Agonists and GLP-1 Receptor Agonists in Heart

The problem is, some people don't make enough GLP-1, which might contribute to weight gain and obesity

This discovery challenges long-held assumptions about glutathione, highlighting its dualistic nature in oncology, and opens revolutionary avenues for targeted cancer therapies designed to starve tumors by inhibiting their glutathione metabolism

Image: Dragana Gordic/Getty Images About the Authors Toni Golen, MD, Editor in Chief, Harvard Women's Health Watch

Clinical Evidence: How Injectable and Transdermal Routes Compare Injectable semaglutide has undergone extensive Phase III trials with clear dose-response relationships and safety profiles